As expected, GSCAR expression positively correlated with glioma stem cell biomarkers, including CD133, CD44, NANOG, ALDH1, Oct4, SOX2, and c-Myc (Figure 5E and Figure S5B). This evidence concerns the gene MYC and central nervous system cancer.